Contineum Therapeutics, Inc.·4

Jun 3, 5:46 PM ET

Healy John Stephen 4

4 · Contineum Therapeutics, Inc. · Filed Jun 3, 2024

Insider Transaction Report

Form 4
Period: 2024-06-03
Healy John Stephen
General Counsel and Corp Sec
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-03+160,000160,000 total
    Exercise: $15.73Exp: 2034-06-02Class A Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on June 3, 2025, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4